Human T-cell lymphotropic virus type 1 exposures following blood-borne virus incidents in Central Australia, 2002-2012

Saliya Hewagama, S Krishnaswamy, L King, Joshua Davis, Robert Baird

Research output: Contribution to journalEditorialResearchpeer-review

Abstract

We retrospectively audited hospital occupational exposure events over a 10-year period, in a human T-cell lymphotropic virus type 1 (HTLV-1)-endemic area of Central Australia, and report on 53 individuals exposed to HTLV-1 with no transmissions documented (95% confidence interval, 0%-1.5%). This has important implications for the management of exposures including the role of postexposure prophylaxis.
Original languageEnglish
Pages (from-to)85-87
Number of pages3
JournalClinical Infectious Diseases
Volume59
Issue number1
DOIs
Publication statusPublished - 2014

Fingerprint

Human T-lymphotropic virus 1
Viruses
T-Lymphocytes
Occupational Exposure
Confidence Intervals

Cite this

@article{d1e228ff89d44cc7be2f46531d5f63f4,
title = "Human T-cell lymphotropic virus type 1 exposures following blood-borne virus incidents in Central Australia, 2002-2012",
abstract = "We retrospectively audited hospital occupational exposure events over a 10-year period, in a human T-cell lymphotropic virus type 1 (HTLV-1)-endemic area of Central Australia, and report on 53 individuals exposed to HTLV-1 with no transmissions documented (95{\%} confidence interval, 0{\%}-1.5{\%}). This has important implications for the management of exposures including the role of postexposure prophylaxis.",
keywords = "lamivudine plus zidovudine, antiviral therapy, article, Australia, exposure, follow up, human, Human T cell leukemia virus 1, Human T cell leukemia virus infection, major clinical study, medical audit, occupational exposure, post exposure prophylaxis, priority journal, retrospective study, risk assessment",
author = "Saliya Hewagama and S Krishnaswamy and L King and Joshua Davis and Robert Baird",
year = "2014",
doi = "10.1093/cid/ciu227",
language = "English",
volume = "59",
pages = "85--87",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "1",

}

Human T-cell lymphotropic virus type 1 exposures following blood-borne virus incidents in Central Australia, 2002-2012. / Hewagama, Saliya; Krishnaswamy, S; King, L; Davis, Joshua; Baird, Robert.

In: Clinical Infectious Diseases, Vol. 59, No. 1, 2014, p. 85-87.

Research output: Contribution to journalEditorialResearchpeer-review

TY - JOUR

T1 - Human T-cell lymphotropic virus type 1 exposures following blood-borne virus incidents in Central Australia, 2002-2012

AU - Hewagama, Saliya

AU - Krishnaswamy, S

AU - King, L

AU - Davis, Joshua

AU - Baird, Robert

PY - 2014

Y1 - 2014

N2 - We retrospectively audited hospital occupational exposure events over a 10-year period, in a human T-cell lymphotropic virus type 1 (HTLV-1)-endemic area of Central Australia, and report on 53 individuals exposed to HTLV-1 with no transmissions documented (95% confidence interval, 0%-1.5%). This has important implications for the management of exposures including the role of postexposure prophylaxis.

AB - We retrospectively audited hospital occupational exposure events over a 10-year period, in a human T-cell lymphotropic virus type 1 (HTLV-1)-endemic area of Central Australia, and report on 53 individuals exposed to HTLV-1 with no transmissions documented (95% confidence interval, 0%-1.5%). This has important implications for the management of exposures including the role of postexposure prophylaxis.

KW - lamivudine plus zidovudine

KW - antiviral therapy

KW - article

KW - Australia

KW - exposure

KW - follow up

KW - human

KW - Human T cell leukemia virus 1

KW - Human T cell leukemia virus infection

KW - major clinical study

KW - medical audit

KW - occupational exposure

KW - post exposure prophylaxis

KW - priority journal

KW - retrospective study

KW - risk assessment

U2 - 10.1093/cid/ciu227

DO - 10.1093/cid/ciu227

M3 - Editorial

VL - 59

SP - 85

EP - 87

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 1

ER -